Till startsida
Sahlgrenska Academy Institute of Neuroscience and Physiology
Sitemap
To content Read more about how we use cookies on gu.se

Contact form




 


Note! If you want an answer on a question you must specify your email address


Jan Lycke

Professor, adjungerad

OverviewPublicationsUNDEFINEDUNDEFINEDUNDEFINED

Jan Lycke
Professor, adjungerad
jan.lycke@gu.se
+46 31-342 9047
0733-109149

Postal Address: Gröna stråket 11, plan 3, 41345 Göteborg
Visiting Address: Neurosjukvården, Gröna stråket 11, plan 3, SU/Sahlgrenska sjukhuset , 41345 Göteborg


Department of Clinical Neuroscience at Institute of Neuroscience and Physiology (More Information)
Box 430
405 30 Göteborg
Visiting Address: Blå stråket 7, plan 3, Sahlgrenska , 413 45 Göteborg

Research areas

Latest publications

Natalizumab, rituximab and fingolimod as escalation therapy in multiple sclerosis
M. Boremalm, A. Juto, Markus Axelsson, Lenka Novakova, T. Frisell et al.
European Journal of Neurology, Journal article 2019
Journal article

Read the full text
on a web page

Cerebrospinal fluid NCAM levels are modulated by disease-modifying therapies
Markus Axelsson, N. Dubuisson, Lenka Novakova, Clas Malmeström, G. Giovannoni et al.
Acta Neurologica Scandinavica, Journal article 2019
Journal article

Read the full text
on a web page

Cerebrospinal fluid levels of glial marker YKL-40 strongly associated with axonal injury in HIV infection
Linn Hermansson, Aylin Yilmaz, M Axelsson, Kaj Blennow, D. Fuchs et al.
Journal of Neuroinflammation, Journal article 2019
Journal article

Read the full text
on a web page

Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension.
Raju Kapoor, Pei-Ran Ho, Nolan Campbell, Ih Chang, Aaron Deykin et al.
The Lancet. Neurology, Journal article 2018
Journal article

Read the full text
on a web page

Sulfatide isoform pattern in cerebrospinal fluid discriminates progressive MS from relapsing-remitting MS
Lenka Novakova, Avadhesh Kumar Singh, Markus Axelsson, Marcus Ståhlman, Martin Adiels et al.
Journal of Neurochemistry, Journal article 2018
Journal article

Read the full text
on a web page

Neurofilament light protein levels in cerebrospinal fluid predict long-term disability of Guillain-Barré syndrome: A pilot study.
Markus Axelsson, Magnus Sjögren, Oluf Andersen, Kaj Blennow, Henrik Zetterberg et al.
Acta neurologica Scandinavica, Journal article 2018
Journal article

Read the full text
on a web page

Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimod
Fredrik Piehl, Ingrid Kockum, Mohsen Khademi, Kaj Blennow, Jan Lycke et al.
Multiple Sclerosis Journal, Journal article 2018
Journal article

Read the full text
on a web page

Searching for neurodegeneration in multiple sclerosis at clinical onset: Diagnostic value of biomarkers.
Lenka Novakova, Markus Axelsson, Clas Malmeström, Henrik Imberg, Henrik Zetterberg et al.
PloS one, Journal article 2018
Journal article

Read the full text
on a web page

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study
Ludwig Kappos, Amit Bar-Or, Bruce A.C. Cree, Robert J. Fox, Gavin Giovannoni et al.
The Lancet, Journal article 2018
Journal article

Read the full text
on a web page

A nationwide survey of the influence of month of birth on the risk of developing multiple sclerosis in Sweden and Iceland
Olöf Eliasdottir, Anders Hildeman, Marco Longfils, Olle Nerman, Jan Lycke
Journal of Neurology, Journal article 2018
Journal article

Read the full text
on a web page

Showing 61 - 67 of 67

2009

Allmän neurologi och multipel skleros
Jan Lycke, Mats Elm
Neurologi. Läkemedelsboken 2009-2010, Apoteket AB, Chapter in book 2009
Chapter in book

Reduced cerebrospinal fluid BACE1 activity in multiple sclerosis.
Niklas Mattsson, M Axelsson, Sara Haghighi, Clas Malmeström, G Wu et al.
Multiple sclerosis (Houndmills, Basingstoke, England), Journal article 2009
Journal article

Read the full text
on a web page

2008

Relapses in multiple sclerosis are associated with increased CD8+ T-cell mediated cytotoxicity in CSF.
Clas Malmeström, Jan Lycke, Sara Haghighi, Oluf Andersen, Lena M S Carlsson et al.
Journal of neuroimmunology, Journal article 2008
Journal article

Read the full text
on a web page

2006

IL-6 and CCL2 levels in CSF are associated with the clinical course of MS: Implications for their possible immunopathogenic roles
Clas Malmeström, Bengt A. Andersson, Sara Haghighi, Jan Lycke
Journal of Neuroimmunology, Journal article 2006
Journal article

Read the full text
on a web page

The aciclovir metabolite CMMG is detectable in the CSF of subjects with neuropsychiatric symptoms during aciclovir and valaciclovir treatment
Anders Helldén, Jan Lycke, Tatiana Vander, Jan-Olof Svensson, Ingegerd Odar-Cederlöf et al.
Journal of Antimicrobial Chemotherapy, Journal article 2006
Journal article

Read the full text
on a web page

2001

Asymptomatic visual loss in multiple sclerosis.
Jan Lycke, Per Olof Tollesson, Lars Frisén
Journal of neurology, Journal article 2001
Journal article

Read the full text
on a web page

1996

Acyclovir treatment of relapsing-remitting multiple sclerosis. A randomized, placebo-controlled, double-blind study.
Jan Lycke, Bo Svennerholm, Elisabeth Hjelmquist, Lars Frisén, Gaby Badr et al.
Journal of neurology, Journal article 1996
Journal article

Read the full text
on a web page

Showing 61 - 67 of 67

Page Manager: Katinka Almrén|Last update: 9/1/2015
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?

Denna text är utskriven från följande webbsida:
http://neurophys.gu.se/english/departments/clinical_neuroscience_and_rehabilitation/about-us/staff/?publicationPageNumber=7&selectedTab=2&feedbackForm=true&returnAddress=http%3A%2F%2Fneurophys.gu.se%2Fenglish%2Fdepartments%2Fclinical_neuroscience_and_rehabilitation%2Fabout-us%2Fstaff%2F%3Fprint%3Dtrue%26languageId%3D100001%26userId%3Dxlycja&recipientName=Katinka+Almr%E9n&encodedEmail=a2F0aW5rYS5hbG1yZW5AbmV1cm8uZ3Uuc2U&languageId=100001&userId=xlycja
Utskriftsdatum: 2019-10-15